Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Tomkin: Targets for intervention in dyslipidemia in diabetes. (0.13 sec) 

Targets for intervention in dyslipidemia in diabetes

- Free from Publisher
GH Tomkin - Diabetes care, 2008 - Am Diabetes Assoc
Treatment for dyslipidemia in diabetes reduces cardiovascular events. Diabetes
is associated with major abnormalities in fatty acid metabolism. The resulting
disturbance results in an abnormal lipoprotein cascade from the large ...
Cited by 6 - Related articles - BL Direct - All 6 versions

Sitosterol and cholesterol in chylomicrons of type 2 diabetic and non-diabetic subjects: …


SE Lally, D Owens, GH Tomkin - Diabetologia, 2007 - Springer
To the Editor: The dyslipidaemia of diabetes is in part related to a disturbance
in genes regulating cholesterol absorption and excretion [1]. Sitosterolaemia is
associated with increased atherosclerosis [2]. The higher the absorp- tion ...
Cited by 3 - Related articles - BL Direct - All 4 versions

The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected …


G Anfossi, C Frascaroli, K Bonomo, M Chirio, … - Current Enzyme Inhibition, 2008 - ingentaconnect.com
Diabetes Unit, Department of Clinical and Biological Sciences of the University
of Turin, San Luigi Gonzaga Faculty of Medicine, San Luigi Gonzaga Hospital,
10043 Orbassano (Turin), Italy Abstract: Ezetimibe is the first ...
Related articles

Statin Utilization Patterns for the Primary Prevention of Cardiovascular Events: A …

- adisonline.com [PDF] 
VWY Lee, ICH Ho, WSY Chan, KY Tam, KKC … - American Journal of Cardiovascular Drugs, 2008 - ingentaconnect.com
Page 1. Am J Cardiovasc Drugs 2008; 8 (3): 199-205 O RIGINAL R ESEARCH A RTICLE
1175-3277/08/0003-0199/$48.00/0 © 2008 Adis Data Information BV. ...
Related articles - All 4 versions

Statut des transporteurs du cholestérol au niveau de l'intestin et du foie dans le diabète de …

- umontreal.ca [PDF] 
G Lalonde, 2009 - papyrus.bib.umontreal.ca
Page 1. Université de Montréal STATUT DES TRANSPORTEURS DU CHOLESTÉROL AU NIVEAU
DE L'INTESTIN ET DU FOIE DANS LE DIABÈTE DE TYPE 2 par Geneviève Lalonde ...
Related articles - View as HTML - All 2 versions

The different effect of pioglitazone as compared to insulin on expression of hepatic and …


S Lally, D Owens, GH Tomkin - Atherosclerosis, 2007 - Elsevier
This study investigates lipoprotein composition in diabetes before and after
treatment with insulin or pioglitazone and its relationship to gene expression
of five genes found in liver and intestine which are involved in ...
Cited by 9 - Related articles - All 16 versions

Macroangiopathy in adults and children with diabetes: from molecular mechanisms to …


D Di Marzio, A Mohn, ZH Mokini, C Giannini, F … - Hormone and metabolic research. Hormon-und …, 2006 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is an increasing problem in childhood; however
type 1 diabetes mellitus (T1DM) remains by far the most common type of diabetes
in this age group. In this review we will focus on T1DM, because this will ...
Cited by 1 - Related articles - BL Direct - All 5 versions

Complications of type 1 diabetes: new molecular findings


A Stirban, P Rösen, D Tschoepe - Mount Sinai Journal of Medicine: A Journal of …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 1 - Related articles - All 2 versions

The Atherogenic Dyslipidemia of Metabolic Syndrome-Are there New Effective Therapeutic …


G Anfossi, M Trovati - Current Drug Therapy, 2007 - ingentaconnect.com
The fundamental defect of patients with the Metabolic Syndrome is the resistance
to insulin action which is involved in the appearance of a combined dyslipidemia
-ie hypertriglyceridemia, low HDL cholesterol, preponderance of small dense ...
Cited by 1 - Related articles - BL Direct

Reducing cardiometabolic risk through selective antagonism of CB1 receptors


L van Gaal - Clinical cornerstone, 2007 - Elsevier
Over the past 15 years, research on the endogenous cannabinoid (CB) system—now
usually referred to as the endocannabinoid system (ECS)—has identified the
significant effects of the ECS on the regulation of food intake and lipid ...
Cited by 2 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google